2 completed, 1 recruiting. 1 Early Phase 1, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow fimepinostat: new trials by email Literature Review of fimepinostat trials Research Report on fimepinostat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease Fimepinostat - Cushing Disease | Phase 2 | Recruiting | University of California, Los Angeles | 20 | 2025-01-16 | 2026-07-17 |
| Fimepinostat in Treating Brain Tumors in Children and Young Adults Fimepinostat, Therapeutic Conventional Surgery - Diffuse Intrinsic Pontine Glioma, Recurrent Anaplastic Astrocytoma | Early Phase 1 | Completed | Sabine Mueller, MD, PhD | 30 | 2019-08-07 | 2026-11-02 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma fimepinostat, Rituximab, venetoclax - Lymphoma, Relapsed Lymphoma | Phase 1 | Completed | Curis, Inc. | 106 | 2012-12-01 | 2021-05-06 |
Astrocytoma (1) · Diffuse Intrinsic Pontine Glioma (1) · Glioblastoma (1) · Glioma (1) · Lymphoma (1) · Lymphoma, Large B-Cell, Diffuse (1) · Medulloblastoma (1) · Pituitary ACTH Hypersecretion (1)
Curis, Inc. (1) · Sabine Mueller, MD, PhD (1) · University of California, Los Angeles (1)
United States (3) · Switzerland (1)